Picture of Mediclinic International logo

MDC Mediclinic International Income Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge Cap

Annual income statement for Mediclinic International, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

C2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2,8762,9323,0832,9953,233
Cost of Revenue
Gross Profit1,0971,1051,123
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,2733,0153,2772,7262,953
Operating Profit-397-83-194269280
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-479-137-275104211
Provision for Income Taxes
Net Income After Taxes-474-130-29979170
Minority Interest
Net Income Before Extraordinary Items
Net Income-492-151-32068151
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-492-151-32068151
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.0050.1550.270.0230.195
Dividends per Share